the whole object this page is drawn from, as JSON · Open JSON {
"id": "atm_site_06c609249d3f2417b338",
"kind": "Website",
"name": "Being Patient",
"parent_id": null,
"depth": null,
"facts": {
"url": "https://beingpatient.com/",
"host": "beingpatient.com",
"forms": 14,
"marin": false,
"pages": 4,
"listings": 1,
"site_kind": "unknown",
"found_from": "https://www.nationalgeographic.com/health/article/alzheimers-drugs-blood-brain-barrier"
},
"source_id": "src_5ad3cc6df1d1e72a55ad",
"updated_at": "2026-10-14T09:03:23.955Z",
"type": "Feature",
"geometry": null,
"links": {
"self": "https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338",
"children": "https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/children",
"descendants": "https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/descendants",
"inside": "https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/inside",
"graph": "https://miscsubjects.com/atlas/graph?start=atm_site_06c609249d3f2417b338"
},
"ancestors": [],
"children_by_kind": [],
"edges_out": [
{
"rel": "links_to",
"id": "atm_site_ce995e622ce9027e3c0a",
"kind": "GovernmentWebsite",
"name": "National Center for Biotechnology Information",
"share": 1
},
{
"rel": "links_to",
"id": "atm_site_038efb649ce1c0d48a21",
"kind": "Website",
"name": "NEW POLL: D.C. Policy Influencers, Small Business Owners and American Voters Demand U.S. Companies Receive Fair Treatmen",
"share": 1
},
{
"rel": "links_to",
"id": "atm_site_055878d4c9c9aa326800",
"kind": "Website",
"name": "Instagram",
"share": 2
},
{
"rel": "links_to",
"id": "atm_site_47ae5ac8229e87684334",
"kind": "Website",
"name": "404 | LEQEMBI® (lecanemab-irmb)",
"share": 1
},
{
"rel": "links_to",
"id": "atm_site_b04bb21c46b2524c3f18",
"kind": "Website",
"name": "ns",
"share": 2
},
{
"rel": "links_to",
"id": "atm_site_b63cd5966bac444c92b2",
"kind": "Website",
"name": "Just a moment...",
"share": 1
},
{
"rel": "links_to",
"id": "atm_site_b994407a8106a51ab870",
"kind": "Website",
"name": "Donanemab Approval Likely to Pose New Quandaries for Clinicians | ALZFORUM",
"share": 1
},
{
"rel": "links_to",
"id": "atm_site_c99fa6738e0b7b99bab3",
"kind": "Website",
"name": "Just a moment...",
"share": 1
},
{
"rel": "publishes",
"id": "atm_form_089011ef471493e4af55",
"kind": "Form",
"name": "Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient",
"share": null
},
{
"rel": "publishes",
"id": "atm_form_29341dd47af2ff8272d5",
"kind": "Form",
"name": "Latest News | Being Patient",
"share": null
},
{
"rel": "publishes",
"id": "atm_form_bdc4c8fb5f51a8f32bf8",
"kind": "Form",
"name": "Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient",
"share": null
},
{
"rel": "publishes",
"id": "atm_form_d33f19c629efc200b4b1",
"kind": "Form",
"name": "Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient",
"share": null
},
{
"rel": "publishes",
"id": "atm_form_d8295a16b4e925effba5",
"kind": "Form",
"name": "Brain Health and Dementia | Being Patient",
"share": null
}
],
"edges_in": [
{
"rel": "links_to",
"id": "atm_site_40126b6e630ae2e3993f",
"kind": "Website",
"name": "Education | National Geographic Society",
"share": 1
}
],
"edges_in_total": 1,
"external_ids": [],
"source": {
"id": "src_5ad3cc6df1d1e72a55ad",
"url": null,
"license": "public web pages, robots.txt honoured",
"read_at": "2026-10-13T23:21:09.844Z",
"sha256": "208b3244e04e88f503da63917fd963b3f4f5a70528be355db4d5f625a8a28164"
},
"observations": [],
"edges_out_total": 13
}